Spinal Cord Injury (SCI)
17
5
5
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
12%
2 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (17)
Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury
ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury
Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
Metformin in Preventing Secondary Gliosis Following Acute Thoraco-Lumbar Spinal Cord Injury
Interdisciplinary Value-based Cognitive Behavioral Treatment for People With Traumatic Spinal Cord Injury
Implant for Walking After Incomplete SCI
Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients With Spinal Cord Injury
Effect of Transauricular Vagal Stimulation on Cardiac Function After Spinal Cord Injury
Control of Assistive Devices Via Brain-Computer Interface Technology
Trunk Balance and Functional Independence in Individuals With SCI
Restoring Walking in Non-ambulatory Children With Severe Chronic Spinal Cord Injury (SCI) (Kids STEP Study)
FLO2 for Recovery After SCI
Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS
Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI
Tissue Bonding Cystostomy(TBC)
Myobloc Atrophy Study
The Effects of L-carnitine on Fatigue in Spinal Cord Injury